VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE
Vertex Pharmaceuticals announced the completion of its Phase III trial of Trikafta in children ages 6 through 11 years with cystic...
![](https://static.wixstatic.com/media/4e4dfc_da79e91563fe43d18f535aeffc2d4d62~mv2.jpeg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_da79e91563fe43d18f535aeffc2d4d62~mv2.webp)
![VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE](https://static.wixstatic.com/media/4e4dfc_da79e91563fe43d18f535aeffc2d4d62~mv2.jpeg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_da79e91563fe43d18f535aeffc2d4d62~mv2.webp)
Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data
Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is safe for use in children with cystic fibrosis (CF) as young as age 6, data...
![](https://static.wixstatic.com/media/4e4dfc_7783cf137490457aa290b1755c7cd0a9~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_7783cf137490457aa290b1755c7cd0a9~mv2.webp)
![Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data](https://static.wixstatic.com/media/4e4dfc_7783cf137490457aa290b1755c7cd0a9~mv2.jpg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_7783cf137490457aa290b1755c7cd0a9~mv2.webp)
Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS
The European Commission and European Medicines Agency have approved the triple combination Kaftrio for use in certain cystic fibrosis...
![](https://static.wixstatic.com/media/4e4dfc_375889add3bc4b96abdb15e0bfce6d60~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_375889add3bc4b96abdb15e0bfce6d60~mv2.webp)
![Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS](https://static.wixstatic.com/media/4e4dfc_375889add3bc4b96abdb15e0bfce6d60~mv2.jpg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_375889add3bc4b96abdb15e0bfce6d60~mv2.webp)
Women With CF Use Combined Hormonal Contraceptives More Than Other Methods, Study Reports
Among women of childbearing age with cystic fibrosis (CF), the use of combined hormonal contraceptives containing both estrogen and...
![](https://static.wixstatic.com/media/4e4dfc_2c0060ba8a8c418ebca1aa6cd92c6cf5~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_2c0060ba8a8c418ebca1aa6cd92c6cf5~mv2.webp)
![Women With CF Use Combined Hormonal Contraceptives More Than Other Methods, Study Reports](https://static.wixstatic.com/media/4e4dfc_2c0060ba8a8c418ebca1aa6cd92c6cf5~mv2.jpg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_2c0060ba8a8c418ebca1aa6cd92c6cf5~mv2.webp)
CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in...
![](https://static.wixstatic.com/media/4e4dfc_56cac04b29094e4cafcd1d670970c2db~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_56cac04b29094e4cafcd1d670970c2db~mv2.webp)
![CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio](https://static.wixstatic.com/media/4e4dfc_56cac04b29094e4cafcd1d670970c2db~mv2.jpg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_56cac04b29094e4cafcd1d670970c2db~mv2.webp)
Kalydeco Approved in Europe to Treat Children with R117H Mutation
The European Commission has approved Vertex’s Kalydeco (ivacaftor) for the treatment of children and adolescents with cystic fibrosis...
![](https://static.wixstatic.com/media/4e4dfc_cca4753a876b45aaafc2f5c6ee4ee9e8~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/4e4dfc_cca4753a876b45aaafc2f5c6ee4ee9e8~mv2.webp)
![Kalydeco Approved in Europe to Treat Children with R117H Mutation](https://static.wixstatic.com/media/4e4dfc_cca4753a876b45aaafc2f5c6ee4ee9e8~mv2.jpg/v1/fill/w_284,h_213,fp_0.50_0.50,q_90,enc_auto/4e4dfc_cca4753a876b45aaafc2f5c6ee4ee9e8~mv2.webp)